G
Giuseppe Paolisso
Researcher at Seconda Università degli Studi di Napoli
Publications - 518
Citations - 36557
Giuseppe Paolisso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 85, co-authored 479 publications receiving 33028 citations. Previous affiliations of Giuseppe Paolisso include National Institutes of Health & University of Udine.
Papers
More filters
Journal ArticleDOI
Preserved Antilipolytic Insulin Action Is Associated with a Less Atherogenic Plasma Lipid Profile in Healthy Centenarians
Giuseppe Paolisso,Antonio Gambardella,S. Ammendola,Maria Tagliamonte,Maria Rosaria Rizzo,Antonio Capurso,Michele Varricchio +6 more
TL;DR: The strong relationship among glucose tolerance, insulin action, plasma lipid concentration, and lipoprotein metabolism would lead to the hypothesis that healthy centenarians may also have a less atherogenic profile than aged subjects less than 100 years old.
Journal ArticleDOI
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients.
Mauro Giordano,Paola Lucidi,Tiziana Ciarambino,L. Gesue,Pietro Castellino,M. Cioffi,P. Gresele,Giuseppe Paolisso,P. De Feo +8 more
TL;DR: LPD in type 2 diabetic patients with diabetic nephropathy reduces low-grade inflammatory state, proteinuria, albuminuria, whole-body proteolysis and ASR of fibrinogen, while increasing albumin FSR, ASR and serum concentration.
Journal ArticleDOI
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study.
Celestino Sardu,M. Massimo Massetti,P. Rambaldi,Gianluca Gatta,Salvatore Cappabianca,Ferdinando Carlo Sasso,Matteo Santamaria,M Volpicelli,Valentino Ducceschi,Giuseppe Signoriello,Giuseppe Paolisso,Raffaele Marfella +11 more
TL;DR: In this article , a prospective multicenter study, after propensity score matching, was performed on 324 patients with type 2 diabetes mellitus with VVS, divided into 161 SGLT2-I-users vs. 163 non-SGLT 2-I users.
Journal ArticleDOI
Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Targets
TL;DR: New biomarkers are joining the already known inflammatory biomarkers, such as C-reactive protein, interleukins, tumor necrosis factor alpha and nitrotyrosine, which might also predict future adverse cardiovascular events and worse prognosis in patients with CVD.
Journal ArticleDOI
Mean arterial blood pressure and serum levels of the molar ratio of insulin-like growth factor-1 to its binding protein-3 in healthy centenarians.
Giuseppe Paolisso,Maria Tagliamonte,Maria Rosaria Rizzo,Mario Rotondi,Pasquale Gualdiero,Antonio Gambardella,Michelangela Barbieri,Carlo Carella,Dario Giugliano,Michele Varricchio +9 more
TL;DR: In healthy centenarians, insulin-like growth factor-1 may preserve endothelial function and modulate the intracellular cation content, thus contributing to a lower mean arterial pressure than that in aged subjects.